Counseling During Pulmonary Rehabilitation
Overview
The purpose of this study is to investigate if a physical activity counseling program during pulmonary rehabilitation increases the physical activity level in daily life in patients with Chronic Obstructive Pulmonary Disease.
Full Title of Study: “Effect of Counseling During Pulmonary Rehabilitation on Self-determined Motivation Towards Physical Activity in Patients With Chronic Obstructive Pulmonary Disease”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Single (Outcomes Assessor)
- Study Primary Completion Date: February 2020
Detailed Description
Participants performed a 12 weeks outpatient pulmonary rehab (PR) according to guidelines. Participants allocated to intervention received PR plus physical activity (PA) counselling. PA counselling was performed using "motivational interviewing" techniques and was provided by two experiences physiotherapists independant to the rehab team. After PR and three months follow-up was evaluated if PA counselling during PR increases PA elvel (primary outcome: steps per day) in daily life. Furthermore, individual, semi-structured interviews were performed in a subgroup of participants in order to gain more detailed information about barriers and enablers of participation in daily-life activities. Participants were invited to two interviews, one right after PR the other after 3 months follow up. A content analysis was performed.
Interventions
- Behavioral: physical activity counseling
- 5 face-to-face sessions a 30 minutes during 12 weeks pulmonary rehabilitation program.
- Behavioral: Usual care
Arms, Groups and Cohorts
- Active Comparator: Usual Care
- outpatient pulmonary Rehabilitation program
- Experimental: Counseling
- outpatient pulmonary Rehabilitation program plus physical activity counseling
Clinical Trial Outcome Measures
Primary Measures
- number of steps per day
- Time Frame: 6 months
Participating in This Clinical Trial
Inclusion Criteria
- confirmed COPD (GOLD stages B-D) according to GOLD-guidelines Exclusion Criteria:
- Mental or physical disability (mini-mental score <20) precluding informed consent or compliance with the protocol – morphine medication – Primary diagnosis of heart failure – Uncontrolled arrhythmias causing symptoms or hemodynamic compromise – Severe co-morbidity (acute coronary syndrome, unstable angina terminal renal failure, concomitant pulmonary embolism, very severe pneumonia: CURB65>3) – Severe untreated arterial hypertension at rest (> 200 mm Hg systolic, > 120 mm Hg diastolic)
Gender Eligibility: All
Minimum Age: 40 Years
Maximum Age: 90 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Zurich University of Applied Sciences
- Collaborator
- Kantonsspital Winterthur KSW
- Provider of Information About this Clinical Study
- Principal Investigator: Anne-Kathrin Rausch, MSc – Zurich University of Applied Sciences
- Overall Official(s)
- Thomas Hess, Dr med, Principal Investigator, Kantonsspital Winterthur KSW
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.